Trinity Biotech plc (NASDAQ:TRIB) Receives Consensus Recommendation of "Hold" from Brokerages
Shares of Trinity Biotech plc have been assigned a consensus rating of "Hold" from the six research firms that are currently covering the firm, MarketBeat.com reports . One research analyst has rated the stock with a sell recommendation, two have given a hold recommendation and three have assigned a buy recommendation to the company.
from Biotech News
0 Comments